BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11060727)

  • 1. Cyclosporin treatment of glomerular diseases.
    Radhakrishnan J; Halevy D
    Expert Opin Investig Drugs; 2000 May; 9(5):1053-63. PubMed ID: 11060727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine treatment of glomerular diseases.
    Klein M; Radhakrishnan J; Appel G
    Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclosporine in glomerular diseases.
    Glassock RJ
    Cleve Clin J Med; 1994; 61(5):363-9. PubMed ID: 7955309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cyclosporine A safe in IgA nephropathy and nephrotic syndrome?
    Révai T; Harmos G
    Clin Nephrol; 1999 Jul; 52(1):66. PubMed ID: 10442503
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis and treatment of primary glomerular diseases. Membranous nephropathy, focal segmental glomerulosclerosis and IgA nephropathy.
    Deegens JK; Wetzels JF
    Minerva Urol Nefrol; 2005 Sep; 57(3):211-36. PubMed ID: 15986018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin in treatment of glomerular diseases].
    Krieter DH; Müller GA
    Internist (Berl); 1996 Jan; 37(1):84-8. PubMed ID: 8837833
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin A in the treatment of patients with nephrotic syndrome.
    Pandeva SM; Tzekov VD; Kumchev EP; Tilkian EE; Nikolov DG; Tzvetkova ZT; Manev EI; Anavi BL; Dimitrakov DJ
    Folia Med (Plovdiv); 2000; 42(2):38-41. PubMed ID: 11217282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A therapy in frequently relapsing nephrotic syndrome and IgA nephropathy.
    Pritchard NR; Milford DV; O'Donoghue DJ
    Nephrol Dial Transplant; 1997 Nov; 12(11):2402-4. PubMed ID: 9394331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG
    Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases.
    Meyrier A
    Nephrol Dial Transplant; 1992; 7 Suppl 1():80-4. PubMed ID: 1337187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of cyclosporin A efficacy in the treatment of steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis--case report].
    Zelichowski G; Nowosławski A; Wawer Z; Wańkowicz Z
    Pol Arch Med Wewn; 2001 Nov; 106(5):1065-9. PubMed ID: 12026521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A treatment for membranoproliferative glomerulonephritis type II.
    Kiyomasu T; Shibata M; Kurosu H; Shiraishi K; Hashimoto H; Hayashidera T; Akiyama Y; Takeda N
    Nephron; 2002 Jul; 91(3):509-11. PubMed ID: 12119488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
    Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC
    Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.
    Cattran DC; Alexopoulos E; Heering P; Hoyer PF; Johnston A; Meyrier A; Ponticelli C; Saito T; Choukroun G; Nachman P; Praga M; Yoshikawa N
    Kidney Int; 2007 Dec; 72(12):1429-47. PubMed ID: 17898700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine in glomerular disease.
    Mowry JA; McCarthy ET
    Semin Nephrol; 1996 Nov; 16(6):548-54. PubMed ID: 9125799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
    Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
    Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels.
    Goumenos DS; Kalliakmani P; Tsakas S; Savidaki I; Vlachojannis JG
    Med Chem; 2006 Jul; 2(4):391-3. PubMed ID: 16848751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.